BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1328 related articles for article (PubMed ID: 1686201)

  • 1. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciguatoxin enhances quantal transmitter release from frog motor nerve terminals.
    Molgó J; Comella JX; Legrand AM
    Br J Pharmacol; 1990 Apr; 99(4):695-700. PubMed ID: 1972891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of protein kinase C increases acetylcholine release from frog motor nerves by a direct action on L-type Ca(2+) channels and apparently not by depolarisation of the terminal.
    Arenson MS; Evans SC
    Neuroscience; 2001; 104(4):1157-64. PubMed ID: 11457598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement by Anemonia sulcata toxin II of spontaneous quantal transmitter release from mammalian motor nerve terminals.
    Molgo J; Lemeignan M; Tazieff-Depierre F
    Toxicon; 1986; 24(5):441-50. PubMed ID: 2872736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of spontaneous release at frog junctions on synaptic strength, external calcium and terminal length.
    Grinnell AD; Pawson PA
    J Physiol; 1989 Nov; 418():397-410. PubMed ID: 2576068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium-dependent increase in quantal secretion induced by brevetoxin-3 in Ca2+-free medium is associated with depletion of synaptic vesicles and swelling of motor nerve terminals in situ.
    Meunier FA; Colasante C; Molgo J
    Neuroscience; 1997 Jun; 78(3):883-93. PubMed ID: 9153666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prejunctional inhibitory effect of suramin on neuromuscular transmission in vitro.
    Henning RH; Rowan EG; Braga MF; Nelemans A; Harvey AL
    Eur J Pharmacol; 1996 Apr; 301(1-3):91-7. PubMed ID: 8773451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic effects of bekanamycin at the frog neuromuscular junction. Reversibility by calcium and aminopyridines.
    Uchiyama T; Molgo J; Lemeignan M
    Eur J Pharmacol; 1981 Jul; 72(4):271-80. PubMed ID: 6268416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Ca2+ channel blockers on transmitter release and presynaptic currents at the frog neuromuscular junction.
    Katz E; Ferro PA; Cherksey BD; Sugimori M; Llinás R; Uchitel OD
    J Physiol; 1995 Aug; 486 ( Pt 3)(Pt 3):695-706. PubMed ID: 7473230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine facilitates calcium-dependent release of transmitter at mouse neuromuscular junctions.
    Nishimura M; Tsubaki K; Yagasaki O; Ito K
    Br J Pharmacol; 1990 May; 100(1):114-8. PubMed ID: 1973623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitation by 3,4-diaminopyridine of regenerative acetylcholine release from mouse motor nerve.
    Hong SJ; Chang CC
    Br J Pharmacol; 1990 Dec; 101(4):793-8. PubMed ID: 1964819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction.
    Thesleff S; Molgó J; Lundh H
    Brain Res; 1983 Mar; 264(1):89-97. PubMed ID: 6133583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by neosurugatoxin and omega-conotoxin of acetylcholine release and muscle and neuronal nicotinic receptors in mouse neuromuscular junction.
    Hong SJ; Tsuji K; Chang CC
    Neuroscience; 1992; 48(3):727-35. PubMed ID: 1318519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium ions and the release of transmitter at the frog neuromuscular junction.
    Crawford AC
    J Physiol; 1975 Mar; 246(1):109-42. PubMed ID: 237119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of carbonyl cyanide m-chlorophenylhydrazone on quantal transmitter release and ultrastructure of frog motor nerve terminals.
    Molgo J; Pecot-Dechavassine M
    Neuroscience; 1988 Feb; 24(2):695-708. PubMed ID: 2834667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic inhibition of quantal transmitter release from the magnesium-paralysed frog sartorius muscle.
    Arenson MS
    Neuroscience; 1989; 30(3):827-36. PubMed ID: 2788830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal by cysteine of the cadmium-induced block of skeletal neuromuscular transmission in vitro.
    Braga MF; Rowan EG
    Br J Pharmacol; 1992 Sep; 107(1):95-100. PubMed ID: 1330169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenthonium, a quaternary derivative of (-)-hyoscyamine, enhances the spontaneous release of acetylcholine at rat motor nerve terminals.
    Fann ML; Souccar C; Lapa AJ
    Br J Pharmacol; 1990 Jul; 100(3):441-6. PubMed ID: 2390670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium dependence of evoked transmitter release at very low quantal contents at the frog neuromuscular junction.
    Andreu R; Barrett EF
    J Physiol; 1980 Nov; 308():79-97. PubMed ID: 6112267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.